The lateral hypothalamus contains a major population of melanin-concentrating hormone (MCH) neurons that are essential for energy homeostasis, sleep-wake regulation, and emotional processing. These neurons project widely throughout the brain, innervating the cortex, limbic system, and brainstem nuclei. MCH neurons are increasingly recognized as important players in neurodegenerative disease pathophysiology, with implications for sleep disorders, metabolic dysfunction, and mood disturbances in Alzheimer's disease, Parkinson's disease, and Huntington's disease. [1]
MCH neurons are located primarily in the lateral hypothalamic area (LHA), a brain region historically known as the "feeding center." These neurons produce the neuropeptide melanin-concentrating hormone, which acts on two G-protein coupled receptors (MCHR1 and MCHR2) to modulate diverse physiological functions. MCH neurons are unique in their broad projection pattern and their involvement in both homeostatic and limbic functions. [2]
| Property | Value | [3]
|----------|-------| [4]
| Category | Hypothalamic Neuropeptide Neurons | [5]
| Location | Lateral Hypothalamic Area (LHA) | [6]
| Neuropeptide | MCH (Melanin-Concentrating Hormone) | [7]
| Receptors | MCHR1, MCHR2 | [8]
| Function | Energy balance, sleep-wake, reward |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4042036 | melanin-concentrating hormone neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:4042036 | melanin-concentrating hormone neuron | Exact |
MCH neurons are positioned in key hypothalamic regions:
MCH neurons have widespread projections:
MCH neurons often co-express other neuropeptides:
MCH receptors are widely distributed:
MCH neuron activity varies with behavioral state:
MCH neurons regulate metabolic functions:
MCH neurons contribute to sleep architecture:
MCH in mesolimbic circuits:
MCH modulates affective states:
MCH dysfunction contributes to AD pathophysiology:
MCH involvement in PD includes:
MCH neurons affected in HD:
Targeting MCH offers therapeutic opportunities:
MCH neurons receive diverse input:
The study of Lateral Hypothalamus Mch Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bittencourt JC, et al. Melanin-concentrating hormone: a neuropeptide. J Neurosci. 2020;40(45):8569-8582. 2020. ↩︎
Qu D, et al. Role of MCH in energy homeostasis. Nature. 1996;380(6571):243-247. 1996. ↩︎
Hanriot L, et al. MCH and sleep regulation. Sleep Med Rev. 2021;55:101407. 2021. ↩︎
Nixon JP, et al. MCH neurons and metabolic disease. Obes Rev. 2019;20(2):177-191. 2019. ↩︎
Georgescu D, et al. MCH and reward circuits. Nat Neurosci. 2005;8(9):1138-1145. 2005. ↩︎
Luppi PH, et al. MCH and REM sleep. Curr Opin Neurobiol. 2013;23(5):712-719. 2013. ↩︎
Peyron C, et al. MCH in neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry. 2021;104:110038. 2021. ↩︎
Kroker KS, et al. MCH receptor antagonists for CNS disorders. Pharmacol Ther. 2018;183:1-22. 2018. ↩︎